{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T00:43:14Z","timestamp":1786236194661,"version":"build-2736575974"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,6,8]],"date-time":"2027-06-08T00:00:00Z","timestamp":1812412800000},"content-version":"am","delay-in-days":342,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01GM145793"],"award-info":[{"award-number":["R01GM145793"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005640","name":"Flight Attendant Medical Research Institute Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005640","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011541","name":"National Cancer Institute Division of Cancer Epidemiology and Genetics","doi-asserted-by":"publisher","award":["DP1CA174428"],"award-info":[{"award-number":["DP1CA174428"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["S10 OD023548"],"award-info":[{"award-number":["S10 OD023548"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["S10OD034217"],"award-info":[{"award-number":["S10OD034217"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA006973"],"award-info":[{"award-number":["P30CA006973"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ejphar.2026.179013","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T05:21:18Z","timestamp":1780118478000},"page":"179013","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["P-glycoprotein\u2013mediated efflux of rapaprotin-L dictates sensitivity of cancer cells to the inducer of 26S proteasome disassembly"],"prefix":"10.1016","volume":"1030","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-0451-4824","authenticated-orcid":false,"given":"Qian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Asbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.V. Subba","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalyan Kumar","family":"Pasunooti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1602-1844","authenticated-orcid":false,"given":"Miyun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7257-4861","authenticated-orcid":false,"given":"Amy F.","family":"Domae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2987-7581","authenticated-orcid":false,"given":"Matthew G.","family":"Rees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9302-2257","authenticated-orcid":false,"given":"Youdong","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3842-9841","authenticated-orcid":false,"given":"Jun O.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.179013_bib1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2026.179013_bib2","article-title":"P-glycoprotein: new insights into structure, physiological function, regulation and alterations in disease","volume":"8","author":"Ahmed","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.ejphar.2026.179013_bib3","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1126\/science.1168750","article-title":"Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding","volume":"323","author":"Aller","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2026.179013_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4137\/DTI.S12519","article-title":"P-glycoprotein inhibition for optimal drug delivery","volume":"7","author":"Amin","year":"2013","journal-title":"Drug Target Insights"},{"key":"10.1016\/j.ejphar.2026.179013_bib5","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1146\/annurev-biochem-062917-011931","article-title":"Structure and function of the 26S proteasome","volume":"87","author":"Bard","year":"2018","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ejphar.2026.179013_bib6","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.3389\/fonc.2020.01273","article-title":"Drug repositioning for P-Glycoprotein mediated Co-Expression networks in colorectal cancer","volume":"10","author":"Beklen","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejphar.2026.179013_bib7","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1023\/A:1026556119020","article-title":"Verapamil increases the survival of patients with anthracycline-resistant metastatic breast carcinoma","volume":"11","author":"Belpomme","year":"2000","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ejphar.2026.179013_bib8","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1523\/JNEUROSCI.1003-21.2021","article-title":"DSCAM deficiency leads to premature spine maturation and autism-like behaviors","volume":"42","author":"Chen","year":"2022","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179013_bib9","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1053\/j.seminoncol.2005.09.009","article-title":"Multidrug resistance\/P-glycoprotein and breast cancer: review and meta-analysis","volume":"32","author":"Clarke","year":"2005","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.ejphar.2026.179013_bib10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s43018-019-0018-6","article-title":"Discovering the anti-cancer potential of non-oncology drugs by systematic viability profiling","volume":"1","author":"Corsello","year":"2020","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.ejphar.2026.179013_bib11","doi-asserted-by":"crossref","first-page":"22118","DOI":"10.1074\/jbc.M601350200","article-title":"Proteasome inhibitors induce death but activate NF-kappaB on endometrial carcinoma cell lines and primary culture explants","volume":"281","author":"Dolcet","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2026.179013_bib12","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s00280-015-2845-1","article-title":"Pharmacokinetic and pharmacodynamic study of tariquidar (XR9576), a P-glycoprotein inhibitor, in combination with doxorubicin, vinorelbine, or docetaxel in children and adolescents with refractory solid tumors","volume":"76","author":"Fox","year":"2015","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179013_bib13","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3389\/fonc.2013.00321","article-title":"Where is it and how does it get there - intracellular localization and traffic of P-glycoprotein","volume":"3","author":"Fu","year":"2013","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejphar.2026.179013_bib14","doi-asserted-by":"crossref","first-page":"W422","DOI":"10.1093\/nar\/gkae236","article-title":"ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support","volume":"52","author":"Fu","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2026.179013_bib15","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41557-018-0187-4","article-title":"Rapamycin-inspired macrocycles with new target specificity","volume":"11","author":"Guo","year":"2019","journal-title":"Nat. Chem."},{"key":"10.1016\/j.ejphar.2026.179013_bib16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.beha.2012.04.007","article-title":"Proteasome inhibitors in mantle cell lymphoma","volume":"25","author":"Holkova","year":"2012","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"10.1016\/j.ejphar.2026.179013_bib17","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.htct.2018.07.003","article-title":"New proteasome inhibitors in the treatment of multiple myeloma","volume":"41","author":"Hungria","year":"2019","journal-title":"Hematol. Transfus Cell Ther."},{"key":"10.1016\/j.ejphar.2026.179013_bib18","article-title":"Functionalized lipid nanocarriers for simultaneous delivery of docetaxel and tariquidar to chemoresistant cancer cells","volume":"16","author":"Kim","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.ejphar.2026.179013_bib19","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1182\/blood-2009-07-229492","article-title":"P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808","volume":"116","author":"Kolitz","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2026.179013_bib20","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/j.1875-9114.1998.tb03142.x","article-title":"Pharmacokinetics of dexamethasone and valspodar, a P-glycoprotein (mdr1) modulator: implications for coadministration","volume":"18","author":"Kovarik","year":"1998","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejphar.2026.179013_bib21","doi-asserted-by":"crossref","first-page":"32777","DOI":"10.1074\/jbc.M113.480921","article-title":"Long-term incubation with proteasome inhibitors (PIs) induces IkappaBalpha degradation via the lysosomal pathway in an IkappaB kinase (IKK)-dependent and IKK-independent manner","volume":"288","author":"Lee","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2026.179013_bib23","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/s41467-024-45461-2","article-title":"DynamicBind: predicting ligand-specific protein-ligand complex structure with a deep equivariant generative model","volume":"15","author":"Lu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2026.179013_bib22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/2050-7771-1-13","article-title":"The resistance mechanisms of proteasome inhibitor bortezomib","volume":"1","author":"Lu","year":"2013","journal-title":"Biomark. Res."},{"key":"10.1016\/j.ejphar.2026.179013_bib24","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1158\/2767-9764.CRC-23-0243","article-title":"Statistical assessment of drug synergy from in vivo combination studies using mouse tumor models","volume":"3","author":"Mao","year":"2023","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.ejphar.2026.179013_bib25","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/febs.12613","article-title":"Understanding polyspecificity within the substrate-binding cavity of the human multidrug resistance P-glycoprotein","volume":"281","author":"Martinez","year":"2014","journal-title":"FEBS J."},{"key":"10.1016\/j.ejphar.2026.179013_bib26","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1023\/A:1022251910820","article-title":"Gene expression profiles of ABC transporters and cytochrome P450 3A in Caco-2 and human colorectal cancer cell lines","volume":"20","author":"Nakumura","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejphar.2026.179013_bib27","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/s41598-018-19325-x","article-title":"Targeted inhibitors of P-glycoprotein increase chemotherapeutic-induced mortality of multidrug resistant tumor cells","volume":"8","author":"Nanayakkara","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.179013_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13071103","article-title":"Pharmaceutical formulations with P-Glycoprotein inhibitory effect as promising approaches for enhancing oral drug absorption and bioavailability","volume":"13","author":"Nguyen","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejphar.2026.179013_bib29","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1292\/jvms.16-0315","article-title":"CAN a P-gp modulator assist in the control of methotrexate concentrations in the rat brain? -inhibitory effects of rhodamine 123, a specific substrate for P-gp, on methotrexate excretion from the rat brain and its optimal route of administration","volume":"79","author":"Ogushi","year":"2017","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.ejphar.2026.179013_bib30","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1200\/JCO.1987.5.4.641","article-title":"Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients","volume":"5","author":"Ozols","year":"1987","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2026.179013_bib31","article-title":"Boltz-2: towards accurate and efficient binding affinity prediction","author":"Passaro","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.ejphar.2026.179013_bib32","series-title":"Rapaprotin is Activated by an Endopeptidase to Disassemble 26S Proteasome","author":"Peng","year":"2025"},{"key":"10.1016\/j.ejphar.2026.179013_bib33","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2220012120","article-title":"A macrocyclic peptide inhibitor traps MRP1 in a catalytically incompetent conformation","volume":"120","author":"Pietz","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2026.179013_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpath.2024.12.004","article-title":"P-Glycoprotein drives glioblastoma survival and chemotherapy resistance: potential as a promising Liquid Biopsy Biomarker","author":"Pilotto Heming","year":"2025","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2026.179013_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e11171","article-title":"P-glycoprotein and cancer: what do we currently know?","volume":"8","author":"Pilotto Heming","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.ejphar.2026.179013_bib36","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/cncr.21227","article-title":"Phase II study of tariquidar, a selective P-glycoprotein inhibitor, in patients with chemotherapy-resistant, advanced breast carcinoma","volume":"104","author":"Pusztai","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.ejphar.2026.179013_bib37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/1878-0261.13318","article-title":"ERBB and P-glycoprotein inhibitors break resistance in relapsed neuroblastoma models through P-glycoprotein","volume":"17","author":"Rosch","year":"2023","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.ejphar.2026.179013_bib38","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1016\/S0021-9258(18)53221-X","article-title":"Human P-glycoprotein transports cyclosporin A and FK506","volume":"268","author":"Saeki","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2026.179013_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24119575","article-title":"Modulation of the endomembrane system by the anticancer natural product Superstolide\/ZJ-101","volume":"24","author":"Sanchez","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179013_bib40","series-title":"The PyMOL Molecular Graphics System","author":"Schr\u00f6dinger","year":"2020"},{"key":"10.1016\/j.ejphar.2026.179013_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23126830","article-title":"Synergistic antiviral activity of pamapimod and pioglitazone against SARS-CoV-2 and its variants of concern","volume":"23","author":"Setz","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179013_bib42","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1158\/1541-7786.MCR-19-1026","article-title":"Proteasome subunits differentially control myeloma cell viability and proteasome inhibitor sensitivity","volume":"18","author":"Shi","year":"2020","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.ejphar.2026.179013_bib43","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.67732","article-title":"De novo macrocyclic peptides dissect energy coupling of a heterodimeric ABC transporter by multimode allosteric inhibition","volume":"10","author":"Stefan","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.ejphar.2026.179013_bib44","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btae416","article-title":"ADMET-AI: a machine learning ADMET platform for evaluation of large-scale chemical libraries","volume":"40","author":"Swanson","year":"2024","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejphar.2026.179013_bib45","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2183\/pjab.85.12","article-title":"The proteasome: overview of structure and functions","volume":"85","author":"Tanaka","year":"2009","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"key":"10.1016\/j.ejphar.2026.179013_bib46","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1124\/pr.117.015370","article-title":"A practical review of proteasome pharmacology","volume":"71","author":"Thibaudeau","year":"2019","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2026.179013_bib47","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.1093\/bioinformatics\/btz213","article-title":"PgpRules: a decision tree based prediction server for P-glycoprotein substrates and inhibitors","volume":"35","author":"Wang","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejphar.2026.179013_bib48","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1046\/j.1365-3083.1996.d01-52.x","article-title":"Inhibition by rapamycin of P-glycoprotein 170-mediated export from normal lymphocytes","volume":"43","author":"Yacyshyn","year":"1996","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.ejphar.2026.179013_bib49","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.semcancer.2019.12.013","article-title":"Repurposing old drugs as new inhibitors of the ubiquitin-proteasome pathway for cancer treatment","volume":"68","author":"Yang","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ejphar.2026.179013_bib50","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1023\/A:1018993312773","article-title":"P-glycoprotein-dependent disposition kinetics of tacrolimus: studies in mdr1a knockout mice","volume":"16","author":"Yokogawa","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejphar.2026.179013_bib51","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1211\/jpp.59.9.0011","article-title":"Role of intestinal efflux transporters in the intestinal absorption of methotrexate in rats","volume":"59","author":"Yokooji","year":"2007","journal-title":"J. Pharm. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926004954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926004954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T00:30:48Z","timestamp":1786235448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926004954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":51,"alternative-id":["S0014299926004954"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179013","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"P-glycoprotein\u2013mediated efflux of rapaprotin-L dictates sensitivity of cancer cells to the inducer of 26S proteasome disassembly","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"179013"}}